Burden and Causes of Hospital Admissions in Heart Failure During the Last Year of Life.

[1]  L. Lund,et al.  Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE‐HF) study , 2018, European journal of heart failure.

[2]  K. Anstrom,et al.  Palliative Care in Heart Failure: The PAL-HF Randomized, Controlled Clinical Trial. , 2017, Journal of the American College of Cardiology.

[3]  Ann Jorgenson,et al.  A Description of Inpatient Palliative Care Actions for Patients With Acute Heart Failure , 2016, The American journal of hospice & palliative care.

[4]  Volkmar Falk,et al.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure , 2016, Revista espanola de cardiologia.

[5]  H. Bøtker,et al.  Thirty‐year trends in heart failure hospitalization and mortality rates and the prognostic impact of co‐morbidity: a Danish nationwide cohort study , 2016, European journal of heart failure.

[6]  L. Allen,et al.  Palliative care in patients with heart failure , 2016, British Medical Journal.

[7]  Peter C Austin,et al.  Lifetime Analysis of Hospitalizations and Survival of Patients Newly Admitted With Heart Failure , 2012, Circulation. Heart failure.

[8]  A. Jha,et al.  Who Has Higher Readmission Rates for Heart Failure, and Why?: Implications for Efforts to Improve Care Using Financial Incentives , 2011, Circulation. Cardiovascular quality and outcomes.

[9]  T. Therneau,et al.  Hospitalizations after heart failure diagnosis a community perspective. , 2009, Journal of the American College of Cardiology.

[10]  Sarah J. Goodlin,et al.  Palliative care in congestive heart failure. , 2009, Journal of the American College of Cardiology.

[11]  S. Normand,et al.  Patterns of Hospital Performance in Acute Myocardial Infarction and Heart Failure 30-Day Mortality and Readmission , 2009, Circulation. Cardiovascular quality and outcomes.

[12]  H. Tsutsui.  [Candesartan in heart failure: assessment of reduction in mortality and morbidity]. , 2007, Nihon rinsho. Japanese journal of clinical medicine.

[13]  G. Fonarow,et al.  Relation of loop diuretic dose to mortality in advanced heart failure. , 2006, The American journal of cardiology.

[14]  Karl Swedberg,et al.  Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial , 2003, The Lancet.

[15]  M. Pfeffer,et al.  Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.

[16]  D. Jacobs,et al.  PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: the Minnesota heart survey. , 1999, Circulation.